Professional Documents
Culture Documents
12199
Abstract
Aim: To compare the clinical benefit of a periodontal dressing applied after a
one-stage full-mouth disinfection (OSFMD) in patients with chronic periodontitis
up to 3 months after therapy.
Material and Methods: This randomized, controlled split-mouth study included
24 patients. After OSFMD, a test and a control side were selected by means of a
computer-generated randomization list. Test sides received a periodontal dressing
(Coepak) for 7 days and the control sides received no periodontal dressing.
After 7 days the periodontal dressing was removed and the pain experience was
recorded. After 3 months, the clinical periodontal parameters were recorded.
Results: The periodontal dressing group showed a significant (p < 0.05) additional pocket depth reduction and additional clinical attachment gain for the
moderate pockets of single- and multi-rooted teeth compared with the control
group. A significant (p < 0.05) lower percentage of sites with probing pocket
depth 5 mm were shown for the periodontal dressing group compared with the
control group (2.7 16.3% versus 4.8 21.4%). The pain intensity was significantly reduced when using a periodontal dressing (5.13 0.89 versus
3.42 1.27).
Conclusion: The use of a periodontal dressing for 7 days after a OSFMD offers
an additional short-term clinical improvement and lowers the pain intensity.
modifying factors (Socransky & Haffajee 1992). The primary clinical signs
are bleeding on probing (BOP),
pocket formation (PPD), gingival
recession (REC) and at a later stage
increased tooth mobility. The goals of
treatment are to reduce the infection,
resolve inflammation and create a
clinical condition, which is compatible with periodontal health (Lang &
Tonetti 2003).
It has been shown that non-surgical periodontal therapy, consisting
of scaling and root planing, results
2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
157
158
Keestra et al.
study. The study started in September 2010 and ended in June 2012.
Twenty-six
volunteers
were
selected for this prospective study
(Fig. 1). All patients consulted or
were referred to the Department of
Periodontology of the University
Hospitals Leuven for the treatment of
chronic periodontitis. The general
health of all the patients was good.
The following inclusion/exclusion criteria had to be fulfilled:
Inclusion criteria
Exclusion criteria
2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
159
Statistical analyses
Results
Variable
Gender (male/female)
Age (years)
Smokers (n)
Total tooth (n)
Multi rooted (n)
Single-rooted (n)
Mean % (number) of sites with
PPD <4 mm
PPD 46 mm
PPD >6 mm
2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
Control
Test
13/11
48.4 9.2
0
304
79
225
13/11
48.4 9.2
0
303
79
224
57.4 49.5
36.1 48
6.5 24.7
54.9 48.8
37.4 48.4
7.8 26.8
BOP, bleeding on probing; CAL, clinical attachment level; PPD, probing pocket depth; PS, plaque score; REC, gingival recession; SE, standard error; SD, standard deviation.
0.4000
0.12
0.0018
7.71
1.00
5.93
1.19
1.83
0.13
0.0018
7.72
1.22
5.78
1.37
2.10
0.13
0.27
>0.9999
<0.0001
<0.0001
0.13
0.03
0.04
0.0018
0.0001
0.0018
0.76
1.76
1.04
0.24
3.94
5.03
1.62
3.21
3.84
1.17
1.44
1.16
1.43
0.74
1.20
0.13
0.07
0.07
0.0018
0.0001
0.0018
0.26
4.03
5.02
0.80
1.81
0.96
1.76
3.03
3.46
1.03
1.46
1.07
1.44
1.01
1.53
0.13
0.07
0.07
0.01
0.26
0.33
0.6032
0.4011
>0.9999
0.15
0.03
0.04
0.0018
0.0001
0.0018
0.16
0.05
0.06
1.20
1.02
0.92
4.01
0.81
0.89
0.96
0.85
0.71
7.46
0.33
0.23
0.0018
0.0001
0.0018
0.16
0.05
0.06
3.27
0.45
0.67
1.29
1.03
1.04
0.73
0.84
0.77
7.47
0.33
0.25
4.31
0.78
0.90
0.0001
0.0018
0.08
0.07
1.20
1.87
1.03
0.84
2.43
2.94
3.56
0.48
0.66
0.0001
0.0018
2.22
2.57
0.95
0.69
1.49
2.20
0.08
0.07
0.30
0.03
0.01
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
2.22
2.11
0.19
0.05
0.05
0.0001
0.0001
43.4
42.9
47.2
47.4
45.5
44.8
0.89
1.64
0.72
33.4
34.0
37.4
38.5
2.47
3.01
0.0001
0.0001
73.0
74.3
3.42
3.69
4.79
44.4
43.7
1.27
1.72
0.74
25.1
24.3
SD
SD
p value
SE
SD
SD
70.8
72.2
5.13
3.62
4.79
PS (% of sites)
BOP (% of sites)
Pain intensity
PPD (mm)
PPD moderate pockets
(46 mm)
PPD deep pockets (>6 mm)
REC (mm)
REC moderate pockets
(46 mm)
REC deep pockets (>6 mm)
CAL (mm)
CAL moderate pockets
(46 mm)
CAL deep pockets (>6 mm)
Variable
Baseline
control
3 months
control
Change control
Baseline test
3 months test
48.2
50.6
2.48
3.01
10.8
12.1
1.71
0.29
0.32
p value
SE
p value
SE
Change test
Keestra et al.
160
Table 3. Number and percentage of subjects presenting low [14 sites with probing
pocket depth (PPD) 5 mm], moderate risk
(58 sites with PPD 5 mm) or high (9
sites with PPD 5 mm) risk for disease progression according to Lang & Tonetti (2003)
Categories
Control
(%)
Test (%)
p value
Low risk
Moderate
risk
High risk
10 (41.7)
5 (20.8)
16 (66.7)
5 (20.8)
0.0422
>0.9999
9 (37.5)
3 (12.5)
<0.0001
2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
Control
Test
p value
4.8 21.3
1.2 10.9
0.4 6.2
2.7 16.3
0.7 8.2
0.2 4.9
<0.0001
0.0066
0.0333
2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
161
162
Keestra et al.
2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
Clinical Relevance
2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
163
Supporting Information